Lawrence Lamb
Company: IN8bio
Job title: Chief Scientific Officer
Seminars:
Maintaining Both Innate Killing & Specific Targeting of Heterogeneous Tumours with Chemotherapy-Resistant Chlorotoxin CAR-T Cells 10:45 am
Tumour heterogeneity can be addressed by upregulating broadly-expressed stress-induced surface antigens with chemotherapy and targeting these antigens with chemotherapy-resistant cells We will discuss the use of Chlorotoxin to improve delivery of CAR-T cells to the tumour site while maintaining their multiple tumour cytolytic functions. Supercharging optimisation and translation of allogeneic productsRead more
day: Day 2 - Track B - Morning
Chair’s Opening Remarks 8:05 am
day: Day Two